These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3361696)

  • 21. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation--A pilot study.
    Yusuf J; Goyal M; Mukhopadhyay S; Mehta V; Dhaiya S; Saxena R; Trehan V
    Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S40-5. PubMed ID: 26688152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation patterns during deheparinization with immobilized polycation.
    von Segesser LK; Mihailevic T; Tönz M; Leskosek B; von Felten A; Turina M
    ASAIO J; 1994; 40(3):M565-9. PubMed ID: 8555578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroperative anticoagulation with antithrombin or heparin in infrainguinal bypass surgery.
    Nydahl S; Swedenborg J; Egberg N
    Eur J Vasc Surg; 1992 Nov; 6(6):610-5. PubMed ID: 1451816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Jones RL
    Diabetes; 1985 Sep; 34(9):836-43. PubMed ID: 4029510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological significance of fibrinopeptide A elevation in the blood].
    Mombelli G; Hofmann V; Straub PW
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1779-81. PubMed ID: 579262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis.
    Atak R; Turhan H; Senen K; Yalta K; Ayaz S; Alyan O; Basar N; Demirkan D
    J Heart Valve Dis; 2004 Mar; 13(2):159-64. PubMed ID: 15086252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transesophageal echocardiographic study on systolic flow pattern of the pulmonary vein in patients with mitral stenosis and atrial fibrillation].
    Iuchi A; Oki T; Ogawa S; Hosoi K; Hayashi M; Kageji Y; Tanimoto M; Yoshimoto K; Fukuda N
    J Cardiol Suppl; 1991; 25():117-28; discussion 129-30. PubMed ID: 1888457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation.
    Sohara H; Amitani S; Kurose M; Miyahara K
    J Am Coll Cardiol; 1997 Jan; 29(1):106-12. PubMed ID: 8996302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation.
    Kalyoncu U; Dizdar O; Erkan Duman A; Karadag O; Tufan A; Yucel O; Tayfur O; Sen D; Ulger Z; Kepez A; Kocabas U; Haznedaroglu I
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):103-8. PubMed ID: 18160605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial coagulation activity in patient with mitral stenosis in sinus rhythm.
    Kiatchoosakun S; Wongvipaporn C; Komanasin N; Tatsanavivat P; Hoit BD
    J Med Assoc Thai; 2013 May; 96(5):544-50. PubMed ID: 23745308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.
    Oltrona L; Broccolino M; Merlini PA; Spinola A; Pezzano A; Mannucci PM
    Circulation; 1997 Apr; 95(8):2003-6. PubMed ID: 9133507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional quantification of left atrial early diastolic strain in two groups of patients with mitral stenosis: normal sinus rhythm vs atrial fibrillation.
    Nikdoust F; Sadeghian H; Lotfi-Tokaldany M
    Echocardiography; 2016 Dec; 33(12):1818-1822. PubMed ID: 27596286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
    Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
    Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
    Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
    J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
    Hayashi I
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):550-61. PubMed ID: 1774012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.